Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Spruce Biosciences, Inc. - Common Stock (NQ:SPRB)

53.70 +0.93 (+1.76%)
Streaming Delayed Price Updated: 10:27 AM EDT, Jun 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Spruce Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Thursday morning! 
Via InvestorPlace
News headline image
Why WISeKey International Is Trading Higher By Over 20%; Here Are 29 Stocks Moving Premarket ↗
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 89.4% to $0.2655 in pre-market trading. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
  
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
During Monday's session, 291 companies made new 52-week lows. Also check out this: Insiders Buying These 4 Penny Stocks Noteable 52-Week Lows And Highs: SAP (... 
Via Benzinga
News headline image
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday ↗
Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial... 
Via Benzinga
News headline image
Spruce Biosciences to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences Reports Second Quarter 2022 Financial Results and Provides Corporate Update
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers Reshape Lifesciences (NASDAQ:RSLS) shares rose 9.4% to $0.81 during Thursday's after-market session. The market value of their outstanding shares is at $2.8 million. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers 
Via Benzinga
News headline image
Spruce Biosciences to Participate in June Investor Conferences
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
74 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Spruce Biosciences Announces Acceptance of Abstract for Presentation at ENDO 2022 Annual Conference
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers 
Via Benzinga
News headline image
Spruce Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate Update
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences to Participate in May Investor Conferences
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences Appoints Libbie Mansell, Ph.D., M.B.A., R.A.C., as Chief Regulatory and Quality Officer
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Where Spruce Biosciences Stands With Analysts ↗
Over the past 3 months, 4 analysts have published their opinion on Spruce Biosciences (NASDAQ:SPRB) stock. These analysts are typically employed by large Wall Street banks and... 
Via Benzinga
News headline image
Spruce Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Updates
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences Appoints Will Charlton, M.D., M.A.S., as Chief Medical Officer
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Gainers Avenue Therapeutics (NASDAQ:ATXI... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
On Monday, 671 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows: Alibaba Group Holding (NYSE:BABA) was the largest firm by... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022 ↗
Upgrades According to Janney Montgomery Scott, the prior rating for Wintrust Financial Corp (NASDAQ:WTFC) was changed from Neutral to Buy. Wintrust Finl earned $1.58 in the fourth... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers Avenue Therapeutics (NASDAQ:ATXI)... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
During Tuesday's trading, 505 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The company with the largest market cap to... 
Via Benzinga
News headline image
Spruce Biosciences to Participate in the SVB Leerink 11th Annual Global Healthcare Conference
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers Provention Bio (NASDAQ:PRVB) shares increased by 16.8% to $3.97 during Friday's pre-market session. The market value of their outstanding shares is at $251.5... 
Via Benzinga
News headline image
Spruce Biosciences Provides Clinical Program Updates and Outlook for 2022
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Good morning, trader! Let's start off the day right with a look into some of the biggest pre-market stock movers for Thursday! 
Via InvestorPlace
News headline image
23 Stocks Moving in Thursday's Pre-Market Session ↗
Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) rose 54.3% to $0.9490 in pre-market trading after declining more than 11% on Wednesday. Alterity Therapeutics Limited... 
Via Benzinga
News headline image
Spruce Biosciences Appoints Javier Szwarcberg, M.D., MPH as Chief Executive Officer
From Spruce Biosciences, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.